PYC Therapeutics Limited
PYCXF
$0.8462
$0.178626.75%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.33M | -8.57M | -7.46M | -7.44M | -4.92M |
| Total Depreciation and Amortization | 96.10K | 98.80K | 241.00K | 240.50K | 109.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.69M | 2.77M | -2.66M | -2.66M | 2.58M |
| Change in Net Operating Assets | -- | -- | -584.80K | -583.60K | -- |
| Cash from Operations | -5.54M | -5.70M | -10.46M | -10.44M | -2.23M |
| Capital Expenditure | -245.20K | -252.10K | -9.10K | -9.10K | -91.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -245.20K | -252.10K | -9.10K | -9.10K | -91.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -86.40K | -86.40K | -79.60K | -79.60K | -67.60K |
| Issuance of Common Stock | -- | -- | 37.33M | 37.33M | 8.70M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -784.40K | -784.40K | -- |
| Cash from Financing | -56.30K | -57.90K | 24.03M | 23.98M | 5.63M |
| Foreign Exchange rate Adjustments | 104.20K | 107.20K | 101.70K | 101.50K | -99.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.74M | -5.90M | 13.66M | 13.63M | 3.21M |